Banner

Cervical Cancer Diagnostics Global Market Report 2023 – By Diagnostic Test (Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests), By End User (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres, Diagnostic Centres), By Age Group (Below 21, Age between 21 to 29, Age between 30 to 65, Above 65) – Market Size, Trends, And Global Forecast 2023-2032

Starting Price : $5000.00 | Pages : 175 | Published : January 2023 | SKU CODE : r1393 | Delivery Time: 2-3 business days | Format :


Cervical cancer is a type of squamous cell carcinoma that occurs in the cervix (the lower part of the uterus). The cervix cancer diagnostic devices are used to diagnose cancer that occurs in the cervix.

The main types of cervical cancer diagnostics are pap smear tests, HPV tests, colposcopy, biopsy, endocervical curettage, and other diagnostic tests. The pap smear test is the process of testing for cervical cancer in women. The age groups involved are those under 21, those between 21 and 29, those between 30 and 65, and those over 65. The end-users involved are hospitals, specialty clinics, cancer and radiation therapy centers, and diagnostic centers.

The cervical cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides cervical cancer diagnostics market statistics, including cervical cancer diagnostics industry global market size, regional shares, competitors with a cervical cancer diagnostics market share, detailed cervical cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cervical cancer diagnostics industry. This cervical cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The global cervical cancer diagnostics market grew from $8.29 billion in 2022 to $8.86 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cervical cancer diagnostics market is expected to grow from $11.03 billion in 2027 at a CAGR of 5.6%.

The rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer is expected to drive the market for cervical cancer diagnostics. Increasing awareness among women about cervical cancer along with the emphasis by worldwide cancer organizations and governments on early testing for detecting cervical cancer and preventing it contributes to the growth of the market. For instance, in August 2020, the World Health Assembly adopted a global strategy to accept cervical cancer as a global challenge and to develop a global strategy to eliminate cervical cancer. First step of this strategy is promoting diagnosis. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the market.

The increased use of HPV vaccination is anticipated to hinder the cervical cancer diagnostics market. According to the World Health Organization, the 2 HPV types (16 and 18) cause 70% of cervical cancers and pre-cancerous cervical lesions, thereby giving human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical pre-cancerous lesions that may develop into cervical cancers. The study published in Cancer Epidemiology, Biomarkers & Prevention, in September 2022, the Union Minister of India announced the launch of India’s first indigenously developed vaccine for cervical cancer. Furthermore, according to National Cancer Institute, one dose of cancer is sufficient for reducing the risk of cervical cancer by a large margin. Therefore, the increased use of HPV vaccination is predicted to hinder the cervical cancer diagnostics market.

The increased adoption of HPV home testing kits is expected to be the new trend in the market. The home-based HPV testing kits help women in collecting samples and getting the results conveniently on their own without going to the lab for screening. Therefore, companies are focusing on providing convenience to patients. For instance, in September 2022, Mylab Discovery Solutions launched the ‘PathoDetectTM HPV PCR detection Kit (Type 16/18). The new product is a home testing kit for detection of HPV type 16 and type 18.

In May 2020, the USA-based firm, Becton, Dickinson & Co., a manufacturer and seller of medical devices, instrument systems, and reagents, announced the acquisition of San Diego biomedical business CareFusion for $12.2 billion. The acquisition is expected to improve the quality of patient care and reduce health care costs by identifying the needs in hospitals, hospital pharmacies, and alternate sites of care.

Major players in the cervical cancer diagnostics market are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, ZiliCo., and Guided Therapeutics.

North America was the largest region in the cervical cancer diagnostics market in 2022. Asia-Pacific was the second largest region in the global cervical cancer diagnostics market. The regions covered in the global cervical cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cervical cancer diagnostics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The cervical cancer diagnostics market consists of sales of analyzer, reagents, and others that are used for the diagnosis of cervical cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The global cervical cancer diagnostics market is segmented -

1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy, and Endocervical Curettage, Other Diagnostic Tests

2) By End User: Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres, Diagnostic Centres

3) By Age Group: Below 21, Age between 21 to 29, Age between 30 to 65, Above 65

    Table Of Contents

    1. Executive Summary

    2. Cervical Cancer Diagnostics Market Characteristics

    3. Cervical Cancer Diagnostics Market Trends And Strategies

    4. Cervical Cancer Diagnostics Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Cervical Cancer Diagnostics Market

    4.2 Ukraine-Russia War Impact On Cervical Cancer Diagnostics Market

    4.3 Impact Of High Inflation On Cervical Cancer Diagnostics Market

    5. Cervical Cancer Diagnostics Market Size And Growth

    5.1. Global Cervical Cancer Diagnostics Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Cervical Cancer Diagnostics Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Cervical Cancer Diagnostics Market Segmentation

    6.1. Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Pap Smear Test

    HPV Test

    Colposcopy

    Biopsy and Endocervical Curettage

    Other Diagnostic Tests

    6.2. Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Hospitals

    Specialty Clinics

    Cancer and Radiation Therapy Centres

    Diagnostic Centres

    6.3. Global Cervical Cancer Diagnostics Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Below 21

    Age between 21 to 29

    Age between 30 to 65

    Above 65

    7. Cervical Cancer Diagnostics Market Regional And Country Analysis

    7.1. Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Cervical Cancer Diagnostics Market

    8.1. Asia-Pacific Cervical Cancer Diagnostics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Cervical Cancer Diagnostics Market

    9.1. China Cervical Cancer Diagnostics Market Overview

    9.2. China Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Cervical Cancer Diagnostics Market

    10.1. India Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Cervical Cancer Diagnostics Market

    11.1. Japan Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Cervical Cancer Diagnostics Market

    12.1. Australia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Cervical Cancer Diagnostics Market

    13.1. Indonesia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Cervical Cancer Diagnostics Market

    14.1. South Korea Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Cervical Cancer Diagnostics Market

    15.1. Western Europe Cervical Cancer Diagnostics Market Overview

    15.2. Western Europe Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Cervical Cancer Diagnostics Market

    16.1. UK Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Cervical Cancer Diagnostics Market

    17.1. Germany Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Cervical Cancer Diagnostics Market

    18.3. France Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Cervical Cancer Diagnostics Market

    19.1. Eastern Europe Cervical Cancer Diagnostics Market Overview

    19.2. Eastern Europe Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Cervical Cancer Diagnostics Market

    20.1. Russia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Cervical Cancer Diagnostics Market

    21.1. North America Cervical Cancer Diagnostics Market Overview

    21.2. North America Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Cervical Cancer Diagnostics Market

    22.1. USA Cervical Cancer Diagnostics Market Overview

    22.2. USA Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Cervical Cancer Diagnostics Market

    23.1. South America Cervical Cancer Diagnostics Market Overview

    23.2. South America Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Cervical Cancer Diagnostics Market

    24.1. Brazil Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Cervical Cancer Diagnostics Market

    25.1. Middle East Cervical Cancer Diagnostics Market Overview

    25.2. Middle East Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Cervical Cancer Diagnostics Market

    26.1. Africa Cervical Cancer Diagnostics Market Overview

    26.2. Africa Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Cervical Cancer Diagnostics Market Competitive Landscape And Company Profiles

    27.1. Cervical Cancer Diagnostics Market Competitive Landscape

    27.2. Cervical Cancer Diagnostics Market Company Profiles

    27.2.1. Abbott Laboratories

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Becton, Dickinson and Co.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Bio-Rad Laboratories Inc.

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. F. Hoffmann-La Roche Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Hologic Inc.

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Cervical Cancer Diagnostics Market

    29. Cervical Cancer Diagnostics Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Historic And Forecast Inflation Rates

    30.4. Research Inquiries

    30.5. The Business Research Company

    30.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Cervical Cancer Diagnostics Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Abbott Laboratories Financial Performance
  • Table 28: Becton, Dickinson and Co. Financial Performance
  • Table 29: Bio-Rad Laboratories Inc. Financial Performance
  • Table 30: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 31: Hologic Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Cervical Cancer Diagnostics Market, Segmentation By Age Group, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Abbott Laboratories Financial Performance
  • Figure 28: Becton, Dickinson and Co. Financial Performance
  • Figure 29: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 30: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 31: Hologic Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report